Multiple Sclerosis: Disease Overview and Management Strategies
Disease Essentials
MS is a chronic, immune-mediated demyelinating disease of the CNS (brain, spinal cord, optic nerves). Peak onset 20–40 years; 3:1 female predominance.
Therapeutic Pillars
- Disease-modifying therapies (DMTs): Reduce relapse rate, new MRI lesions, disability progression. Options: injectables (interferons, glatiramer), oral (fingolimod, dimethyl fumarate, teriflunomide, siponimod), infusions (natalizumab, ocrelizumab, alemtuzumab). Selection by phenotype, risk tolerance, comorbidities.
- Relapse management: High-dose IV methylprednisolone ± plasma exchange.
- Symptomatic treatment: Spasticity (baclofen, tizanidine), fatigue (amantadine, modafinil), neuropathic pain (gabapentin, duloxetine), bladder/bowel, depression, cognitive rehab.
- Rehabilitation: PT, OT, speech/swallow therapy, vocational counseling.
- Lifestyle: Vitamin D optimization, smoking cessation, exercise, heat avoidance.
Multidisciplinary MS centers optimize outcomes. No cure yet, but early DMT use improves long-term prognosis.
Multiple Sclerosis - Related Articles
- White Matter Lesions on Brain MRI: MS and Many Other Causes
- Scleroderma: Causes, Risk Factors, and Pathophysiology
- Multiple Sclerosis (MS): Understanding Potential Causes & Risk Factors
- The MS Recovery Diet: A Guide to Managing Multiple Sclerosis Symptoms
- Managing Social Media When You Have MS
- MS in Children: Headaches and Other Symptoms - A Comprehensive Overview
- Multiple Sclerosis Symptoms: Understanding What to Look For
